Humabs BioMed, subsidiary of Vir Biotechnology reposted this
Last week at our #VirBiotechnology #HepatitisAwarenessMonth event, we collaborated with @SFHepBFree on a #hepatitis panel discussion. We learned so much – from navigating a #hepatitisB diagnosis to all the hurdles patients experience along the way. Patient voices are a powerful force that not only shed light on the realities of living with this devastating disease, but also continue to inspire our work as we pursue innovative treatment options, including a functional cure. #Patientsarewaiting
